Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Xanthyletin
Cat. No.:
OB0225LY-0237
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Xanthyletin is a compound with anti-inflammatory, anti-tumor and anti-bacterial activities.
Synonym:
553-19-5; Xanthyletine; 2,2-Dimethylpyrano[3,2-g]chromen-8-one; 8,8-Dimethyl-2H,8H-pyrano[3,2-g]chromen-2-one; 8,8-Dimethyl-8H-pyrano[3,2-g]chromen-2-one; 8,8-Dimethyl-2H,8H-benzo(1,2-b:5,4-b')dipyran-2-one
CAS No.:
553-19-5
Compound CID:
65188
Formula:
C14H12O3
Formula Weight:
228.24
Specification
Relative Density:
1.222 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Xanthyletin t can be used for antioxidant characterization or play an important role in pharmacology.
Library Information
Targets:
MAPK family; MMP family
Receptors:
ERK; MMP
Pathways:
Proteases/Proteasome; MAPK; Microbiology/Virology
Plate Number:
AOCL-3
Plate Location:
h11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
60 mg/ml; 262.88 mM
